NO990225L - Medikamenter for behandling av hyperfosfatemi - Google Patents

Medikamenter for behandling av hyperfosfatemi

Info

Publication number
NO990225L
NO990225L NO990225A NO990225A NO990225L NO 990225 L NO990225 L NO 990225L NO 990225 A NO990225 A NO 990225A NO 990225 A NO990225 A NO 990225A NO 990225 L NO990225 L NO 990225L
Authority
NO
Norway
Prior art keywords
hyperphosphatemia
drug
treatment
medications
ions
Prior art date
Application number
NO990225A
Other languages
English (en)
Other versions
NO990225D0 (no
Inventor
Yoshiyuki Sasaki
Yutaka Ishii
Original Assignee
Nikken Chemicals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nikken Chemicals Co Ltd filed Critical Nikken Chemicals Co Ltd
Publication of NO990225D0 publication Critical patent/NO990225D0/no
Publication of NO990225L publication Critical patent/NO990225L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Et medikament som omfatter som en aktiv bestanddel, en svakt bas- isk anionbytterresin som danner chelat med jern(III)ioner, fortrinnsvis en re- sin av polyamintypen eller akryltypen. Medikamentet har utmerket adsorberende evne og selektivitet for fosfationer og adsorberer effektivt fosfationer in vivo og er således anvendelig for tera- peutisk og/eller preventiv behandling av hyperfosfatemi.
NO990225A 1996-07-19 1999-01-18 Medikamenter for behandling av hyperfosfatemi NO990225L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP20757496 1996-07-19
JP3146197 1997-01-31
PCT/JP1997/002486 WO1998003185A1 (en) 1996-07-19 1997-07-17 Remedies for hyperphosphatemia

Publications (2)

Publication Number Publication Date
NO990225D0 NO990225D0 (no) 1999-01-18
NO990225L true NO990225L (no) 1999-03-18

Family

ID=26369934

Family Applications (1)

Application Number Title Priority Date Filing Date
NO990225A NO990225L (no) 1996-07-19 1999-01-18 Medikamenter for behandling av hyperfosfatemi

Country Status (7)

Country Link
US (1) US6180094B1 (no)
EP (1) EP0922461A4 (no)
KR (1) KR20000067929A (no)
CN (1) CN1230118A (no)
CA (1) CA2261750A1 (no)
NO (1) NO990225L (no)
WO (1) WO1998003185A1 (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001241076A1 (en) * 2000-03-09 2001-09-17 Hisamitsu Pharmaceutical Co. Inc. Crosslinked anion-exchange resin or salt thereof
AU2001241077A1 (en) 2000-03-09 2001-09-17 Hisamitsu Pharmaceutical Co. Inc. Crosslinked anion-exchange resin or salt thereof and phosphorus adsorbent comprising the same
AU2004285450B2 (en) 2003-10-20 2010-01-14 Gregory K. Frykman Zeolite molecular sieves for the removal of toxins
US7385012B2 (en) 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
US7767768B2 (en) * 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7335795B2 (en) 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
US7459502B2 (en) * 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US7449605B2 (en) * 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
US7608674B2 (en) * 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
WO2005065291A2 (en) * 2003-12-31 2005-07-21 Genzyme Corporation Enteric coated aliphatic amine polymer bile acid sequestrants
PT2184059E (pt) * 2004-03-30 2012-07-06 Relypsa Inc Polímeros de ligação a ião e seus usos
WO2006072054A1 (en) * 2004-12-30 2006-07-06 Genzyme Corporation Zinc-containing treatments for hyperphosphatemia
US8986669B2 (en) 2005-09-02 2015-03-24 Genzyme Corporation Method for removing phosphate and polymer used therefore
EP1945196A2 (en) * 2005-11-08 2008-07-23 Genzyme Corporation Magnesium-containing polymers for hyperphosphatemia
MY157620A (en) * 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
CN100398112C (zh) * 2006-03-24 2008-07-02 辽宁诺康生物制药有限责任公司 一种治疗血磷酸盐过多症的药物及其制备方法
WO2008005217A2 (en) * 2006-07-05 2008-01-10 Genzyme Corporation Iron(ii)-containing treatments for hyperphosphatemia
CN101568349B (zh) * 2006-10-25 2012-09-19 威斯康星大学校友研究基金会 减少磷酸盐吸收的方法
JP2010508281A (ja) 2006-10-26 2010-03-18 ウィスコンシン・アラムナイ・リサーチ・ファウンデイション リン酸塩吸収の低減方法
CA2625522A1 (en) 2007-04-20 2008-10-20 Rohm And Haas Company Method for removing phosphate from aqueous solutions
CN108938585A (zh) 2009-07-21 2018-12-07 凯克斯生物制药公司 柠檬酸铁剂型
WO2011125758A1 (ja) * 2010-03-31 2011-10-13 富田製薬株式会社 透析組成物、血液透析システムおよび血液透析器
AU2011358606B2 (en) 2011-02-11 2014-10-30 Colgate-Palmolive Company Methods of analyzing plaque
SG11201408521WA (en) * 2012-06-21 2015-01-29 Keryx Biopharmaceuticals Inc Use of ferric citrate in the treatment of chronic kidney disease patients
TWI653043B (zh) * 2012-12-20 2019-03-11 瑞士商伊蘭科動物健康公司 新用途
CN104258829B (zh) * 2014-09-24 2016-08-31 珠海健帆生物科技股份有限公司 血磷吸附剂及其制备方法、用于血液灌流的吸附柱
CN111773247B (zh) * 2020-07-24 2022-04-05 荆门市第一人民医院 蔗糖铁在制备治疗高磷血症诱导的血管钙化药物中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3228231A1 (de) * 1982-07-28 1984-02-02 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 8000 München Arzneimittel, calciummischsalze von polymeren, anionischen carbonsaeuren und/oder schwefelsaeureestern, verfahren zu ihrer herstellung und ihre verwendung
CA2042870C (en) * 1991-05-17 1996-11-26 Leon Edward St. Pierre Metal ion coordinated polyamine resins for the lowering of blood cholesterol
US5487888A (en) 1993-05-20 1996-01-30 Geltex, Inc. Iron-binding polymers for oral administration
JPH072903A (ja) * 1993-06-11 1995-01-06 Tatsuaki Yamaguchi アセチル化鉄キトサン錯体、その製法および用途
US5496545A (en) * 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
JPH09157283A (ja) * 1995-12-13 1997-06-17 Tatsuaki Yamaguchi 燐酸吸着コロイド
ES2162658T3 (es) * 1996-03-05 2002-01-01 Mitsubishi Chem Corp Utilizacion de resinas intercambiadoras anionicas para la fabricacion de un medicamento destinado al tratamiento de la hiperfosfatemia.

Also Published As

Publication number Publication date
US6180094B1 (en) 2001-01-30
KR20000067929A (ko) 2000-11-25
CA2261750A1 (en) 1998-01-29
CN1230118A (zh) 1999-09-29
EP0922461A1 (en) 1999-06-16
EP0922461A4 (en) 2002-07-17
NO990225D0 (no) 1999-01-18
WO1998003185A1 (en) 1998-01-29

Similar Documents

Publication Publication Date Title
NO990225L (no) Medikamenter for behandling av hyperfosfatemi
MX9604354A (es) Nueva forma de dosis farmaceutica oral.
TR200000129T2 (tr) Yepyeni spiroazabisiklik heterosiklik bileşikler.
CA2282654A1 (en) Use of cholinesterase inhibitors to treat attention deficit hyperactivity disorder
EP0509317A3 (en) Use of droloxifene in the treatment of bone diseases
ZA933768B (en) Novel phosphonosulfonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism metabolism.
SK288630B6 (sk) Farmaceutická kompozícia zahrnujúca 40-O-(2-hydroxyetyl)rapamycín na použitie ako jediná aktívna zložka pri liečení pevných nádorov pľúc alebo priedušiek iných ako lymfatická rakovina
AU2002321105A1 (en) Use of hepcidin for preparing a medicament for treating disorders of iron homeostasis
CA2180535A1 (en) A method for treatment of psoriasis, by omeprazole or related compounds
JO2373B1 (en) W-carboxy-aryl diphenyl urease substitutes used as RAV inhibitors
PL374443A1 (en) Novel pyrimidineamide derivatives and the use thereof
DE58905201D1 (de) Mittel zur behandlung des parkinson-syndroms.
ZA200005217B (en) α-sulfonylamino hydroxamic acid inhibitors of matrix metalloproteinases for the treatment of peripheral or central nervous system disorders.
DE68914436D1 (de) Therapeutisches system zum plasmaaustausch.
FI961282A7 (fi) Transdermaalinen terapeuttinen systeemi, jossa on asetyylisalisyylihap po vaikuttavana aineena
CA2344407A1 (en) Method for the treatment of mania and bipolar disorder
ATE275966T1 (de) Activin stimulator enthaltende pharmazeutische zusammensetzung
AU3260093A (en) Use of creatine phosphate or phosphoenolpyruvic acid for the treatment of tumours
DK0634396T3 (da) Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer
MY113431A (en) Substituted benzenesulfonylureas and -thioureas, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
CA2380078A1 (en) Combination therapy using pentafluorobenzenesulfonamides
SE9702066L (sv) Nytt salt
ES2086359T3 (es) R(-)-1-(5-hidroxihexil)-3-metil-7-propilxantina, procedimiento para su preparacion y medicamentos que contienen este compuesto.
WO2004026252A3 (en) Glioma treatments
IL142247A0 (en) Method of treating sickle cell disease and thalassemia

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application